Imricor Medical Systems, Inc. (ASX:IMR)
Australia · Delayed Price · Currency is AUD 1.325
+0.025 (1.92%)
Jul 22, 2025, 4:20 PM AEST
Imricor Medical Systems Company Description
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.
The company’s product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator.
Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning.
Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Imricor Medical Systems, Inc.
| Country | United States |
| Founded | 2006 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Steven Wedan |
Contact Details
Address: 400 Gateway Boulevard Burnsville, Delaware 55337 United States | |
| Phone | 952 818 8400 |
| Website | imricor.com |
Stock Details
| Ticker Symbol | IMR |
| Exchange | Australian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | AU0000054942 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Steven Wedan | President, Chief Executive Officer and Executive Chairman |
| Jonathon Gut | Chief Financial Officer and Vice President of Finance |
| Gregg Stenzel | Chief Operating Officer |
| Greg Englehardt | Vice President of Global Sales |
| Nick Twohy | Vice President of Marketing and Business Development |
| Kobe Lizheng | Company Secretary |